log in
Print | Back

Walder Wyss Ltd.

Annemarie Lagger

Annemarie Lagger

Senior Associate

Profile
Annemarie Lagger is a senior associate in the Information Technology, Intellectual Property and Competition Team. She advises on intellectual property law (trademark, copyright and and unfair competition law) and on matters of life science (including food and drug law) as well as information technology (including online media platforms and shops). She has a special focus on issues where these areas of law overlap. Her work includes all matters relating to the drafting of contracts (such as license and distribution agreements), regulatory clarifications prior to product launches and representing the client before courts and administrative bodies.

Annemarie Lagger studied International Affairs and Governance at the Universities of Geneva (B.A. 2008), Singapore and St.Gallen (M.A. HSG, 2012) and Law at the University of St.Gallen (M.A. HSG in Law, 2014). Before joining Walder Wyss AG she had gained working experience with NGOs in Canada (2009) and in Ghana (2011). Subsequently, she worked in the legal department of a bulk shipping company in Hamburg (2011-2013). She was admitted to the bar in 2017. Annemarie Lagger publishes on an occasional basis.

Annemarie Lagger's professional languages are German, English and French. She is registered with the Zurich Bar Registry and admitted to practice in all Switzerland.
Areas of Practice

Healthcare & Life Sciences | Information Technology & Telecommunications | Intellectual Property & Technology Transfer | Litigation | Media & Communications | Outsourcing | Trade & Distribution

Professional Career

Significant Accomplishments


Hitachi ABB Power Grids lagert Betrieb der IT-Infrastruktur an HCL Technologies aus

Walder Wyss lanciert ICT-Podcast

ABB lagert Hosting-Infrastruktur und -Management an Tata Consultancy Services (TCS) aus

Medbase erwirbt Mehrheitsbeteiligung an zahnarztzentrum.ch

Neues Handbuch: Lebensmittel- und Gebrauchsgegenständerecht

Walder Wyss advises global aesthetic manufacturer Teoxane Laboratories on Exclusive U.S. Distribution Agreement of FDA-Approved RHA Dermal Fillers with Revance Therapeutics, Inc.

SEED erwirbt Mehrheitsbeteiligung an der Sensimed AG

ImmunOs Therapeutics AG raises CHF 15m in Series A Financing

Avaloq erwirbt Derivative Partners, einen Zürcher Service-Spezialisten für strukturierte Produkte

Neuraxpharm Group steigt mit der Übernahme der S.T.U. GmbH in den CBD-Markt ein

Metall Zug (SIX: METN) übernimmt Mehrheit an der Haag-Streit Holding AG


Articles


Nahrungsergänzungsmittel: Unzulässige Werbung mit dem Wirkstoff CBD. Urteil des Bundesgerichts 2C_733/2020 vom 15. März 2021
Anbieter von OTT-Diensten qualifizieren als beitragsorientierte Altersversorgungspläne
Vorgeschlagene Revision des Filmgesetzes: Investitionsverpflichtung für Online-Filmanbieter und Quoten für europäische Filme
Zentraler Angriff gegen Schweizer Basis im Rahmen des Madrider Markenabkommens stellt rechtliches Interesse in der Nichtigkeitsklage dar
New requirements for film and video game platforms under proposed youth protection legislation
Well-known trademarks in the context of a product’s culinary origin
Medicinal Product Names: New Guidance Document
Swissmedic issues guidelines on product names for medicinal products
Anforderungen an Lebensmittel und Gebrauchsgegenstände
Bundesrat bietet Onlinemedien finanzielle Unterstützung an
Jugendschutz im Zusammenhang mit Filmen und Videospielen: Beratungsphase hat begonnen
Highlights des Vorentwurfs des Bundesgesetzes über elektronische Medien


WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2021